Connections Evaxion A/S

EVAX

US29970R3030

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 00:00:00 12/03/2026 +04			5-day change	1st Jan Change
3.870 ^USD	+8.10%		+24.44%	-18.87%

03-10	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT
03-09	European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	MT

7

Listed companies

0

Private companies

23

Insiders

Relation chart of related listed companies: Evaxion A/S

Active Relations

Past Relations

Related listed companies: Evaxion A/S

IMMUNOCORE HOLDINGS PLC

JoAnn Suzich

RALLYBIO CORPORATION

Helen Boudreau

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Biotechnology	3
Packaged Software	1
Medical Specialties	1
Information Technology Services	1
Pharmaceuticals: Major	1

Countries of related companies

Sweden	2
United States	2
Denmark	2
United Kingdom	1

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Employees

Sector

Biotechnology & Medical Research

Calendar

05-07 - Earnings release - Q1 2026

More about the company